drugset / Trial / NCT01802515
A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
RandomizedParallel-groupDouble-blindTreatment
Summary
The main goal of this study is to evaluate the safety and tolerability of 40 or 80 mg atomoxetine as a treatment for cocaine dependence. The Phase I studies summarized above support the safety of atomoxetine in combination with stimulants. As the next step, the investigators will evaluate the safety and tolerability of atomoxetine in a small clinical trial with cocaine users. If atomoxetine is found to be promising in this study and sufficiently powered, double-blind, placebo-controlled studies will be proposed.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atomoxetine | Other / unclassified | 40 mg | Oral |
| Comparator | Atomoxetine | Other / unclassified | 80 mg | Oral |